This article is part of Harvard Medical School’s continuing coverage of COVID-19.
New research has provided important insight into why some people fail to fully regain their sense of smell even months after recovering from COVID-19.
The study, published Dec. 21 in Science Translational Medicine and conducted by researchers at Duke Health, Harvard Medical School, and the University of California San Diego, reveals that long-term loss of smell may be linked to an ongoing immune assault on olfactory nerve cells and an associated decline in the number of those cells.
“This paper allows us to look, for the first time, at COVID-19-associated smell loss in otherwise healthy people — a clinical condition that has affected millions in the United States alone,” said Sandeep Robert Datta, professor of neurobiology in the Blavatnik Institute at HMS and an author on the paper.
An immune assault
Loss of smell is one of the first symptoms that has typically been associated with COVID-19, said senior author Bradley Goldstein, associate professor in Duke’s Department of Head and Neck Surgery and Communication Sciences and the Department of Neurobiology.
Goldstein added that many people who experience an altered sense of smell during the acute phase of SARS-CoV-2 infection recover within one to two weeks, but some do not.
“We need to better understand why this subset of people will go on to have persistent smell loss for months to years after being infected with SARS-CoV-2,” Goldstein said.
Previously, Datta and his team identified the olfactory cell types that are most vulnerable to infection with SARS-CoV-2. In their 2020 paper in Science Advances, they concluded that the virus primarily infects cells that provide metabolic and structural support to olfactory sensory neurons.
“Based on these results, we hypothesized that short-term loss of support causes transient loss of smell, while more persistent infection causes a more profound disruption in olfactory function that can take longer to recover from,” Datta said.
In the new study, the researchers wanted to further investigate the olfactory epithelium — the tissue in the nose where olfactory nerve cells are located — in people with long-term smell loss. The team collected olfactory epithelial samples from a small group of otherwise healthy people who were still experiencing smell loss at least four months after SARS-CoV-2 infection. They then performed single-cell sequencing on the samples to determine the different cell types present.
Science & Medicine, Delivered
Harvard Medicine magazine in your inbox